Stephen J Seiner
Overview
Explore the profile of Stephen J Seiner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
206
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wade B, Pindale R, Luccarelli J, Li S, Meisner R, Seiner S, et al.
NPJ Digit Med
. 2025 Feb;
8(1):127.
PMID: 40016503
Electroconvulsive therapy (ECT) and ketamine are effective treatments for depression; however, evidence-based guidelines are needed to inform individual treatment selection. We adapted the Personalized Advantage Index (PAI) using machine learning...
2.
Ren C, Kung S, Croarkin P, Opitz A, Forester B, Hermida A, et al.
J ECT
. 2025 Jan;
PMID: 39853304
Electroconvulsive therapy (ECT) is an effective treatment for severe depression, especially in treatment-resistant cases. However, its potential cognitive side effects necessitate careful dosing to balance therapeutic benefits and cognitive stability....
3.
Kryatova M, Seiner S, Brown J, Siddiqi S
J Affect Disord
. 2024 Jan;
351:66-73.
PMID: 38244806
Background: TMS is increasingly used to treat depression, but predictors of treatment outcomes remain unclear. We assessed the association between age and TMS response given inconsistent prior reports limited by...
4.
Rhee T, Shim S, Popp J, Trikalinos T, Rosenheck R, Kellner C, et al.
Mol Psychiatry
. 2023 Dec;
29(3):750-759.
PMID: 38123725
Objective: To meta-analyze clinical efficacy and safety of ketamine compared with other anesthetic agents in the course of electroconvulsive therapy (ECT) in major depressive episode (MDE). Methods: PubMed/MEDLINE, Cochrane Library,...
5.
Park S, Forester B, Lapid M, Harper D, Hermida A, Inouye S, et al.
J Geriatr Psychiatry Neurol
. 2023 Oct;
37(3):234-241.
PMID: 37848185
Objective: To develop an individualized method for detecting cognitive adverse events (CAEs) in the context of an ongoing trial of electroconvulsive therapy for refractory agitation and aggression for advanced dementia...
6.
Hart K, McCoy Jr T, Henry M, Seiner S, Luccarelli J
J Affect Disord
. 2023 Sep;
341:374-378.
PMID: 37661058
Background: Residual depressive symptoms following treatment are a burden for patients and are associated with increased risk of relapse. While this phenomenon has been explored following pharmacotherapy, there is little...
7.
Luccarelli J, Humphrey D, McCoy Jr T, Henry M, Mueller M, Seiner S
Acta Psychiatr Scand
. 2023 Aug;
148(6):553-560.
PMID: 37643775
Objective: Suicidal ideation (SI) is common in patients with depressive symptoms, who are the most common recipients of electroconvulsive therapy (ECT). We sought to quantify changes in self-reported SI occurring...
8.
Copersino M, DeTore N, Piltch C, Bolton P, Henderson T, Davis V, et al.
J ECT
. 2023 Aug;
39(4):248-254.
PMID: 37530733
Objectives: Concerns about the cognitive adverse effects of electroconvulsive therapy (ECT) are common among recipients of the treatment despite its relatively small adverse effects on cognitive functioning. Interventions aimed at...
9.
Becker C, Taylor J, Brown J, Seiner S, Siddiqi S
Brain Stimul
. 2023 May;
16(3):901-903.
PMID: 37230463
No abstract available.
10.
Hart K, McCoy Jr T, Henry M, Seiner S, Luccarelli J
Acta Psychiatr Scand
. 2023 Feb;
147(4):322-332.
PMID: 36744383
Objective: Electroconvulsive therapy (ECT) is an effective treatment for severe depressive symptoms, yet more research is needed to examine predictors of treatment response, and factors associated with response in patients...